NCT03304756View on ClinicalTrials.gov

Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 15, 2007

Primary Completion Date

April 15, 2012

Study Completion Date

December 15, 2014

Conditions
Triple Negative Breast Cancer Patients
Interventions
DRUG

CAP

cisplatin (50 mg/m2) in combination with doxorubicin (50 mg/m2) and cyclophosphamide (500 mg/m2) every 21 days and for a total of 6 cycles

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

lead

Instituto Nacional de Cancer, Brazil

OTHER_GOV

NCT03304756 - Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen | Biotech Hunter | Biotech Hunter